Vir Biotechnology, Inc.
VIR • NASDAQ
Vir Biotechnology, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marianne De Backer, with a market cap of $1.6B.
Market Cap$1.6B
Employees587.0
CEOMarianne De Backer
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Vir Biotechnology, Inc. FAQ
Common questions about Vir Biotechnology, Inc.
Vir Biotechnology, Inc. is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $135.8M.
Vir Biotechnology, Inc. has approximately 587 employees.